BACKGROUND: It is generally assumed that with increasing age, pathology in clinically diagnosed Alzheimer's disease (AD) becomes more mixed, i.e., co-existence of amyloid plaques and cerebrovascular pathology. OBJECTIVE: To test the hypothesis of increasing prevalence of mixed dementia in late-onset clinically diagnosed Alzheimer's disease (AD) in a single-center memory clinic population. METHODS: Patients included had diagnoses of AD (n = 832), subjective cognitive impairment (SCI, n = 333), mild cognitive impairment (MCI, n = 492), vascular dementia (VaD, n = 57), other dementia (n = 53), or other diagnosis (n = 233). Prevalence of severe white matter lesions (WML) was defined as a score of 2 or higher on the Fazekas-scale on brain computed tomography to classify AD patients as having mixed dementia. We examined the effect of age on WML using multiple linear regression analysis, and AD patients were compared to SCI to determine the effect of disease on WML. RESULTS: Prevalence of severe WML was 33.6% in AD patients (mixed dementia), 11.4% in SCI, 22.7% in MCI, 75.4% in VaD, 3.8% in other dementia, and 15.5% in other diagnosis. With increasing age there was a significant and similar increase of WML scores in SCI, MCI, AD, other dementia, and other diagnosis, indicating no effect modification by AD. The difference between AD patients and SCI averaged 0.16 on the WML score and difference in percentage severe WML between AD and SCI patients was 15% across all ages. CONCLUSION: We found a low prevalence of mixed dementia. Furthermore, severe WML in AD was largely explained by age rather than effect of disease.
BACKGROUND: It is generally assumed that with increasing age, pathology in clinically diagnosed Alzheimer's disease (AD) becomes more mixed, i.e., co-existence of amyloid plaques and cerebrovascular pathology. OBJECTIVE: To test the hypothesis of increasing prevalence of mixed dementia in late-onset clinically diagnosed Alzheimer's disease (AD) in a single-center memory clinic population. METHODS:Patients included had diagnoses of AD (n = 832), subjective cognitive impairment (SCI, n = 333), mild cognitive impairment (MCI, n = 492), vascular dementia (VaD, n = 57), other dementia (n = 53), or other diagnosis (n = 233). Prevalence of severe white matter lesions (WML) was defined as a score of 2 or higher on the Fazekas-scale on brain computed tomography to classify ADpatients as having mixed dementia. We examined the effect of age on WML using multiple linear regression analysis, and ADpatients were compared to SCI to determine the effect of disease on WML. RESULTS: Prevalence of severe WML was 33.6% in ADpatients (mixed dementia), 11.4% in SCI, 22.7% in MCI, 75.4% in VaD, 3.8% in other dementia, and 15.5% in other diagnosis. With increasing age there was a significant and similar increase of WML scores in SCI, MCI, AD, other dementia, and other diagnosis, indicating no effect modification by AD. The difference between ADpatients and SCI averaged 0.16 on the WML score and difference in percentage severe WML between AD and SCI patients was 15% across all ages. CONCLUSION: We found a low prevalence of mixed dementia. Furthermore, severe WML in AD was largely explained by age rather than effect of disease.
Authors: Hanneke F M Rhodius-Meester; Marije R Benedictus; Mike P Wattjes; Frederik Barkhof; Philip Scheltens; Majon Muller; Wiesje M van der Flier Journal: Front Aging Neurosci Date: 2017-05-09 Impact factor: 5.750
Authors: Marianne M Flak; Haakon R Hol; Susanne S Hernes; Linda Chang; Thomas Ernst; Andreas Engvig; Knut Jørgen Bjuland; Bengt-Ove Madsen; Elisabeth M S Lindland; Anne-Brita Knapskog; Ingun D Ulstein; Trine E E Lona; Jon Skranes; Gro C C Løhaugen Journal: Front Aging Neurosci Date: 2018-11-21 Impact factor: 5.750
Authors: Tarik T Binnekade; Roberto Sgm Perez; Andrea B Maier; Hanneke Fm Rhodius-Meester; Nienke Legdeur; Marijke C Trappenburg; Didi Rhebergen; Frank Lobbezoo; Erik Ja Scherder Journal: J Pain Res Date: 2019-05-22 Impact factor: 3.133
Authors: Carl Eckerström; Marie Eckerström; Mattias Göthlin; Anna Molinder; Michael Jonsson; Petronella Kettunen; Johan Svensson; Sindre Rolstad; Anders Wallin Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Stefan Klöppel; Shan Yang; Elias Kellner; Marco Reisert; Bernhard Heimbach; Horst Urbach; Jennifer Linn; Stefan Weidauer; Tamara Andres; Maximilian Bröse; Jacob Lahr; Niklas Lützen; Philipp T Meyer; Jessica Peter; Ahmed Abdulkadir; Sabine Hellwig; Karl Egger Journal: Neuroimage Clin Date: 2018-09-19 Impact factor: 4.881